GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (STU:78D) » Definitions » Additional Paid-In Capital

Alzinova AB (STU:78D) Additional Paid-In Capital : €16.89 Mil(As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Alzinova AB Additional Paid-In Capital?


Alzinova AB's quarterly additional paid-in capital declined from Sep. 2024 (€16.45 Mil) to Dec. 2024 (€16.09 Mil) but then increased from Dec. 2024 (€16.09 Mil) to Mar. 2025 (€16.89 Mil).

Alzinova AB's annual additional paid-in capital increased from Dec. 2022 (€13.16 Mil) to Dec. 2023 (€14.86 Mil) and increased from Dec. 2023 (€14.86 Mil) to Dec. 2024 (€16.09 Mil).

Alzinova AB Additional Paid-In Capital Historical Data

The historical data trend for Alzinova AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Additional Paid-In Capital Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 11.68 11.57 13.16 14.86 16.09

Alzinova AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.69 14.73 16.45 16.09 16.89

Alzinova AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Alzinova AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzinova AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (STU:78D) » Definitions » Additional Paid-In Capital
Comparable Companies
NGM:GTAB B OSTO:ISOFOL OSTO:BIOSGN XSAT:ABERA XSAT:BIOWKS OSTO:KAN OSTO:MVIR XSAT:DEX OSTO:INIT XSAT:CURAS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ALZ:Sweden
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Website
https://www.alzinova.com
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB Headlines

No Headlines